메뉴 건너뛰기




Volumn 1, Issue 5, 2013, Pages 433-440.e1

Alternative Agents in Refractory Chronic Urticaria: Evidence and Considerations on Their Selection and Use

Author keywords

Alternative agent; Anti inflammatory; Chronic; Immunomodulatory; Immunosuppressant; Refractory; Urticaria

Indexed keywords

ADALIMUMAB; ANTIHISTAMINIC AGENT; AUTOANTIBODY; COLCHICINE; CREATININE; CYCLOSPORIN; CYTOKINE; DAPSONE; ETANERCEPT; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E ANTIBODY; INFLIXIMAB; INTERLEUKIN 1 ANTIBODY; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHOTREXATE; MONTELUKAST; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OMALIZUMAB; PLACEBO; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; STEROID; TACROLIMUS; ANTIINFLAMMATORY AGENT; IMMUNOLOGIC FACTOR;

EID: 84883461501     PISSN: 22132198     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaip.2013.06.003     Document Type: Article
Times cited : (52)

References (58)
  • 1
    • 0031895903 scopus 로고    scopus 로고
    • The characteristics of urticaria in 390 patients
    • Humphreys F., Hunter J.A. The characteristics of urticaria in 390 patients. Br J Dermatol 1998, 138:635-638.
    • (1998) Br J Dermatol , vol.138 , pp. 635-638
    • Humphreys, F.1    Hunter, J.A.2
  • 2
    • 43449123325 scopus 로고    scopus 로고
    • Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1
    • quiz 12-4, 68
    • Morgan M., Khan D.A. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 1. Ann Allergy Asthma Immunol 2008, 100:403-411. quiz 12-4, 68.
    • (2008) Ann Allergy Asthma Immunol , vol.100 , pp. 403-411
    • Morgan, M.1    Khan, D.A.2
  • 3
    • 45149086027 scopus 로고    scopus 로고
    • Therapeutic alternatives for chronic urticaria: an evidence-based review, part 2
    • quiz 26-8, 44
    • Morgan M., Khan D.A. Therapeutic alternatives for chronic urticaria: an evidence-based review, part 2. Ann Allergy Asthma Immunol 2008, 100:517-526. quiz 26-8, 44.
    • (2008) Ann Allergy Asthma Immunol , vol.100 , pp. 517-526
    • Morgan, M.1    Khan, D.A.2
  • 4
    • 0020557329 scopus 로고
    • Wheal reactions in human skin after injection of leukotrienes B4, C4, D4 and E4
    • Juhlin L., Hammarstrom S. Wheal reactions in human skin after injection of leukotrienes B4, C4, D4 and E4. Prostaglandins Leukot Med 1983, 11:381-383.
    • (1983) Prostaglandins Leukot Med , vol.11 , pp. 381-383
    • Juhlin, L.1    Hammarstrom, S.2
  • 5
    • 45949111525 scopus 로고    scopus 로고
    • Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features
    • Criado R.F., Criado P.R., Martins J.E., Valente N.Y., Michalany N.S., Vasconcellos C. Urticaria unresponsive to antihistaminic treatment: an open study of therapeutic options based on histopathologic features. JDermatolog Treat 2008, 19:92-96.
    • (2008) JDermatolog Treat , vol.19 , pp. 92-96
    • Criado, R.F.1    Criado, P.R.2    Martins, J.E.3    Valente, N.Y.4    Michalany, N.S.5    Vasconcellos, C.6
  • 6
    • 33746897708 scopus 로고    scopus 로고
    • Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine
    • Godse K.V. Oral montelukast monotherapy is ineffective in chronic idiopathic urticaria: a comparison with oral cetirizine. Indian J Dermatol Venereol Leprol 2006, 72:312-314.
    • (2006) Indian J Dermatol Venereol Leprol , vol.72 , pp. 312-314
    • Godse, K.V.1
  • 7
    • 77953391610 scopus 로고    scopus 로고
    • Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review
    • Di Lorenzo G., D'Alcamo A., Rizzo M., Leto-Barone M.S., Bianco C.L., Ditta V., et al. Leukotriene receptor antagonists in monotherapy or in combination with antihistamines in the treatment of chronic urticaria: a systematic review. JAsthma Allergy 2008, 2:9-16.
    • (2008) JAsthma Allergy , vol.2 , pp. 9-16
    • Di Lorenzo, G.1    D'Alcamo, A.2    Rizzo, M.3    Leto-Barone, M.S.4    Bianco, C.L.5    Ditta, V.6
  • 8
    • 0036736841 scopus 로고    scopus 로고
    • The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study
    • Erbagci Z. The leukotriene receptor antagonist montelukast in the treatment of chronic idiopathic urticaria: a single-blind, placebo-controlled, crossover clinical study. JAllergy Clin Immunol 2002, 110:484-488.
    • (2002) JAllergy Clin Immunol , vol.110 , pp. 484-488
    • Erbagci, Z.1
  • 9
    • 0034785961 scopus 로고    scopus 로고
    • Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid
    • Pacor M.L., Di Lorenzo G., Corrocher R. Efficacy of leukotriene receptor antagonist in chronic urticaria. A double-blind, placebo-controlled comparison of treatment with montelukast and cetirizine in patients with chronic urticaria with intolerance to food additive and/or acetylsalicylic acid. Clin Exp Allergy 2001, 31:1607-1614.
    • (2001) Clin Exp Allergy , vol.31 , pp. 1607-1614
    • Pacor, M.L.1    Di Lorenzo, G.2    Corrocher, R.3
  • 10
    • 0347933014 scopus 로고    scopus 로고
    • The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results
    • Bagenstose S.E., Levin L., Bernstein J.A. The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results. JAllergy Clin Immunol 2004, 113:134-140.
    • (2004) JAllergy Clin Immunol , vol.113 , pp. 134-140
    • Bagenstose, S.E.1    Levin, L.2    Bernstein, J.A.3
  • 11
  • 12
    • 4444359777 scopus 로고    scopus 로고
    • Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria
    • Di Lorenzo G., Pacor M.L., Mansueto P., Esposito Pellitteri M., Lo Bianco C., et al. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. JAllergy Clin Immunol 2004, 114:619-625.
    • (2004) JAllergy Clin Immunol , vol.114 , pp. 619-625
    • Di Lorenzo, G.1    Pacor, M.L.2    Mansueto, P.3    Esposito Pellitteri, M.4    Lo Bianco, C.5
  • 14
    • 0031724541 scopus 로고    scopus 로고
    • Successful treatment of chronic urticaria with leukotriene antagonists
    • Ellis M.H. Successful treatment of chronic urticaria with leukotriene antagonists. JAllergy Clin Immunol 1998, 102:876-877.
    • (1998) JAllergy Clin Immunol , vol.102 , pp. 876-877
    • Ellis, M.H.1
  • 15
    • 0031980764 scopus 로고    scopus 로고
    • Antileukotrienes in chronic urticaria
    • Spector S., Tan R.A. Antileukotrienes in chronic urticaria. JAllergy Clin Immunol 1998, 101(4 Pt 1):572.
    • (1998) JAllergy Clin Immunol , vol.101 , Issue.1-4 , pp. 572
    • Spector, S.1    Tan, R.A.2
  • 16
    • 2442446959 scopus 로고    scopus 로고
    • Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation
    • Reeves G.E., Boyle M.J., Bonfield J., Dobson P., Loewenthal M. Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation. Intern Med J 2004, 34:182-186.
    • (2004) Intern Med J , vol.34 , pp. 182-186
    • Reeves, G.E.1    Boyle, M.J.2    Bonfield, J.3    Dobson, P.4    Loewenthal, M.5
  • 17
    • 79551548116 scopus 로고    scopus 로고
    • American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy
    • Marmor M.F., Kellner U., Lai T.Y., Lyons J.S., Mieler W.F. American Academy of Ophthalmology. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 2011, 118:415-422.
    • (2011) Ophthalmology , vol.118 , pp. 415-422
    • Marmor, M.F.1    Kellner, U.2    Lai, T.Y.3    Lyons, J.S.4    Mieler, W.F.5
  • 18
    • 41149112504 scopus 로고    scopus 로고
    • Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria
    • Engin B., Ozdemir M. Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. JEur Acad Dermatol Venereol 2008, 22:481-486.
    • (2008) JEur Acad Dermatol Venereol , vol.22 , pp. 481-486
    • Engin, B.1    Ozdemir, M.2
  • 19
    • 0032863883 scopus 로고    scopus 로고
    • Urticaria treated with dapsone
    • Boehm I., Bauer R., Bieber T. Urticaria treated with dapsone. Allergy 1999, 54:765-766.
    • (1999) Allergy , vol.54 , pp. 765-766
    • Boehm, I.1    Bauer, R.2    Bieber, T.3
  • 20
    • 18844403333 scopus 로고    scopus 로고
    • Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study
    • Cassano N., D'Argento V., Filotico R., Vena G.A. Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study. Acta Derm Venereol 2005, 85:254-255.
    • (2005) Acta Derm Venereol , vol.85 , pp. 254-255
    • Cassano, N.1    D'Argento, V.2    Filotico, R.3    Vena, G.A.4
  • 21
    • 84883456733 scopus 로고    scopus 로고
    • Double-blind placebo controlled (DBPC) trial of dapsone in antihistamine refractory chronic idiopathic urticaria (CIU)
    • [abstract]
    • Cooke A., Morgan M., Rogers L., Huet-Adams B., Khan D.A. Double-blind placebo controlled (DBPC) trial of dapsone in antihistamine refractory chronic idiopathic urticaria (CIU). JAllergy Clin Immunol 2013, 131:AB143. [abstract].
    • (2013) JAllergy Clin Immunol , vol.131
    • Cooke, A.1    Morgan, M.2    Rogers, L.3    Huet-Adams, B.4    Khan, D.A.5
  • 22
    • 33750049299 scopus 로고    scopus 로고
    • Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine
    • McGirt L.Y., Vasagar K., Gober L.M., Saini S.S., Beck L.A. Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine. Arch Dermatol 2006, 142:1337-1342.
    • (2006) Arch Dermatol , vol.142 , pp. 1337-1342
    • McGirt, L.Y.1    Vasagar, K.2    Gober, L.M.3    Saini, S.S.4    Beck, L.A.5
  • 23
    • 0028893828 scopus 로고
    • Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema
    • Engler R.J., Squire E., Benson P. Chronic sulfasalazine therapy in the treatment of delayed pressure urticaria and angioedema. Ann Allergy Asthma Immunol 1995, 74:155-159.
    • (1995) Ann Allergy Asthma Immunol , vol.74 , pp. 155-159
    • Engler, R.J.1    Squire, E.2    Benson, P.3
  • 24
    • 79955745323 scopus 로고    scopus 로고
    • Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria
    • Sagi L., Solomon M., Baum S., Lyakhovitsky A., Trau H., Barzilai A. Evidence for methotrexate as a useful treatment for steroid-dependent chronic urticaria. Acta Derm Venereol 2011, 91:303-306.
    • (2011) Acta Derm Venereol , vol.91 , pp. 303-306
    • Sagi, L.1    Solomon, M.2    Baum, S.3    Lyakhovitsky, A.4    Trau, H.5    Barzilai, A.6
  • 25
    • 72749128298 scopus 로고    scopus 로고
    • Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria
    • Perez A., Woods A., Grattan C.E. Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria. Br J Dermatol 2010, 162:191-194.
    • (2010) Br J Dermatol , vol.162 , pp. 191-194
    • Perez, A.1    Woods, A.2    Grattan, C.E.3
  • 27
    • 0024596713 scopus 로고
    • Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine
    • Lawlor F., Black A.K., Ward A.M., Morris R., Greaves M.W. Delayed pressure urticaria, objective evaluation of a variable disease using a dermographometer and assessment of treatment using colchicine. Br J Dermatol 1989, 120:403-408.
    • (1989) Br J Dermatol , vol.120 , pp. 403-408
    • Lawlor, F.1    Black, A.K.2    Ward, A.M.3    Morris, R.4    Greaves, M.W.5
  • 28
    • 43549100660 scopus 로고    scopus 로고
    • Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation
    • Serhat Inaloz H., Ozturk S., Akcali C., Kirtak N., Tarakcioglu M. Low-dose and short-term cyclosporine treatment in patients with chronic idiopathic urticaria: a clinical and immunological evaluation. JDermatol 2008, 35:276-282.
    • (2008) JDermatol , vol.35 , pp. 276-282
    • Serhat Inaloz, H.1    Ozturk, S.2    Akcali, C.3    Kirtak, N.4    Tarakcioglu, M.5
  • 31
    • 0141740375 scopus 로고    scopus 로고
    • Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation
    • Di Gioacchino M., Di Stefano F., Cavallucci E., Verna N., Ramondo S., Paolini F., et al. Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation. Allergy Asthma Proc 2003, 24:285-290.
    • (2003) Allergy Asthma Proc , vol.24 , pp. 285-290
    • Di Gioacchino, M.1    Di Stefano, F.2    Cavallucci, E.3    Verna, N.4    Ramondo, S.5    Paolini, F.6
  • 33
    • 33749021931 scopus 로고    scopus 로고
    • Neo-I-30 Study Group. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial
    • Vena G.A., Cassano N., Colombo D., Peruzzi E., Pigatto P. Neo-I-30 Study Group. Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial. JAm Acad Dermatol 2006, 55:705-709.
    • (2006) JAm Acad Dermatol , vol.55 , pp. 705-709
    • Vena, G.A.1    Cassano, N.2    Colombo, D.3    Peruzzi, E.4    Pigatto, P.5
  • 34
    • 82955227419 scopus 로고    scopus 로고
    • Factors that predict the success of cyclosporine treatment for chronic urticaria
    • Hollander S.M., Joo S.S., Wedner H.J. Factors that predict the success of cyclosporine treatment for chronic urticaria. Ann Allergy Asthma Immunol 2011, 107:523-528.
    • (2011) Ann Allergy Asthma Immunol , vol.107 , pp. 523-528
    • Hollander, S.M.1    Joo, S.S.2    Wedner, H.J.3
  • 36
    • 78649309440 scopus 로고    scopus 로고
    • Cyclosporine-A in severe chronic urticaria: the option for long-term therapy
    • Kessel A., Toubi E. Cyclosporine-A in severe chronic urticaria: the option for long-term therapy. Allergy 2010, 65:1478-1482.
    • (2010) Allergy , vol.65 , pp. 1478-1482
    • Kessel, A.1    Toubi, E.2
  • 37
    • 17344362950 scopus 로고    scopus 로고
    • No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis
    • van den Borne B.E., Landewe R.B., Houkes I., Schild F., van der Heyden P.C., Hazes J.M., et al. No increased risk of malignancies and mortality in cyclosporin A-treated patients with rheumatoid arthritis. Arthritis Rheum 1998, 41:1930-1937.
    • (1998) Arthritis Rheum , vol.41 , pp. 1930-1937
    • van den Borne, B.E.1    Landewe, R.B.2    Houkes, I.3    Schild, F.4    van der Heyden, P.C.5    Hazes, J.M.6
  • 38
    • 84863898895 scopus 로고    scopus 로고
    • Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology
    • Muellenhoff M.W., Koo J.Y. Cyclosporine and skin cancer: an international dermatologic perspective over 25 years of experience. A comprehensive review and pursuit to define safe use of cyclosporine in dermatology. JDermatolog Treat 2012, 23:290-304.
    • (2012) JDermatolog Treat , vol.23 , pp. 290-304
    • Muellenhoff, M.W.1    Koo, J.Y.2
  • 39
    • 0028291307 scopus 로고
    • Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis
    • Laburte C., Grossman R., Abi-Rached J., Abeywickrama K.H., Dubertret L. Efficacy and safety of oral cyclosporin A (CyA; Sandimmun) for long-term treatment of chronic severe plaque psoriasis. Br J Dermatol 1994, 130:366-375.
    • (1994) Br J Dermatol , vol.130 , pp. 366-375
    • Laburte, C.1    Grossman, R.2    Abi-Rached, J.3    Abeywickrama, K.H.4    Dubertret, L.5
  • 40
    • 0032792540 scopus 로고    scopus 로고
    • Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group
    • Ho V.C., Griffiths C.E., Albrecht G., Vanaclocha F., Leon-Dorantes G., Atakan N., et al. Intermittent short courses of cyclosporin (Neoral(R)) for psoriasis unresponsive to topical therapy: a 1-year multicentre, randomized study. The PISCES Study Group. Br J Dermatol 1999, 141:283-291.
    • (1999) Br J Dermatol , vol.141 , pp. 283-291
    • Ho, V.C.1    Griffiths, C.E.2    Albrecht, G.3    Vanaclocha, F.4    Leon-Dorantes, G.5    Atakan, N.6
  • 41
    • 11144344480 scopus 로고    scopus 로고
    • Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study
    • Kessel A., Bamberger E., Toubi E. Tacrolimus in the treatment of severe chronic idiopathic urticaria: an open-label prospective study. JAm Acad Dermatol 2005, 52:145-148.
    • (2005) JAm Acad Dermatol , vol.52 , pp. 145-148
    • Kessel, A.1    Bamberger, E.2    Toubi, E.3
  • 42
    • 33749853951 scopus 로고    scopus 로고
    • Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids
    • Shahar E., Bergman R., Guttman-Yassky E., Pollack S. Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and/or corticosteroids. Int J Dermatol 2006, 45:1224-1227.
    • (2006) Int J Dermatol , vol.45 , pp. 1224-1227
    • Shahar, E.1    Bergman, R.2    Guttman-Yassky, E.3    Pollack, S.4
  • 43
    • 84859854630 scopus 로고    scopus 로고
    • The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients
    • Zimmerman A.B., Berger E.M., Elmariah S.B., Soter N.A. The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: experience in 19 patients. JAm Acad Dermatol 2011, 66:767-770.
    • (2011) JAm Acad Dermatol , vol.66 , pp. 767-770
    • Zimmerman, A.B.1    Berger, E.M.2    Elmariah, S.B.3    Soter, N.A.4
  • 44
    • 79959855552 scopus 로고    scopus 로고
    • Efficacy and safety of omalizumab in patients with chronic urticaria whoexhibit IgE against thyroperoxidase
    • Maurer M., Altrichter S., Bieber T., Biedermann T., Brautigam M., Seyfried S., et al. Efficacy and safety of omalizumab in patients with chronic urticaria whoexhibit IgE against thyroperoxidase. JAllergy Clin Immunol 2011, 128:202-209.e5.
    • (2011) JAllergy Clin Immunol , vol.128
    • Maurer, M.1    Altrichter, S.2    Bieber, T.3    Biedermann, T.4    Brautigam, M.5    Seyfried, S.6
  • 46
    • 80052299857 scopus 로고    scopus 로고
    • Arandomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria
    • Saini S., Rosen K.E., Hsieh H.J., Wong D.A., Conner E., Kaplan A., et al. Arandomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. JAllergy Clin Immunol 2011, 128:567-573.e1.
    • (2011) JAllergy Clin Immunol , vol.128
    • Saini, S.1    Rosen, K.E.2    Hsieh, H.J.3    Wong, D.A.4    Conner, E.5    Kaplan, A.6
  • 47
    • 84874732930 scopus 로고    scopus 로고
    • Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria
    • Maurer M., Rosen K., Hsieh H.J., Saini S., Grattan C., Gimenez-Arnau A., et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. NEngl J Med 2013, 368:924-935.
    • (2013) NEngl J Med , vol.368 , pp. 924-935
    • Maurer, M.1    Rosen, K.2    Hsieh, H.J.3    Saini, S.4    Grattan, C.5    Gimenez-Arnau, A.6
  • 50
    • 77649173981 scopus 로고    scopus 로고
    • Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria
    • Mitzel-Kaoukhov H., Staubach P., Muller-Brenne T. Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria. Ann Allergy Asthma Immunol 2010, 104:253-258.
    • (2010) Ann Allergy Asthma Immunol , vol.104 , pp. 253-258
    • Mitzel-Kaoukhov, H.1    Staubach, P.2    Muller-Brenne, T.3
  • 52
    • 79956105670 scopus 로고    scopus 로고
    • Treatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitors
    • [letter]
    • Wilson L.H., Eliason M.J., Leiferman K.M., Hull C.M., Powell D.L. Treatment of refractory chronic urticaria with tumor necrosis factor-alfa inhibitors. JAm Acad Dermatol 2011, 64:1221-1222. [letter].
    • (2011) JAm Acad Dermatol , vol.64 , pp. 1221-1222
    • Wilson, L.H.1    Eliason, M.J.2    Leiferman, K.M.3    Hull, C.M.4    Powell, D.L.5
  • 53
    • 59449084387 scopus 로고    scopus 로고
    • Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria [letter]
    • author reply 511
    • Arkwright P.D. Anti-CD20 or anti-IgE therapy for severe chronic autoimmune urticaria [letter]. JAllergy Clin Immunol 2009, 123:510-511. author reply 511.
    • (2009) JAllergy Clin Immunol , vol.123 , pp. 510-511
    • Arkwright, P.D.1
  • 54
    • 82555165971 scopus 로고    scopus 로고
    • Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies
    • Chakravarty S.D., Yee A.F., Paget S.A. Rituximab successfully treats refractory chronic autoimmune urticaria caused by IgE receptor autoantibodies. JAllergy Clin Immunol 2011, 128:1354-1355.
    • (2011) JAllergy Clin Immunol , vol.128 , pp. 1354-1355
    • Chakravarty, S.D.1    Yee, A.F.2    Paget, S.A.3
  • 55
    • 80053369287 scopus 로고    scopus 로고
    • Severe steroid-dependent idiopathic angioedema with response to rituximab
    • Ghazan-Shahi S., Ellis A.K. Severe steroid-dependent idiopathic angioedema with response to rituximab. Ann Allergy Asthma Immunol 2011, 107:374-376.
    • (2011) Ann Allergy Asthma Immunol , vol.107 , pp. 374-376
    • Ghazan-Shahi, S.1    Ellis, A.K.2
  • 56
    • 33947700338 scopus 로고    scopus 로고
    • Lack of response of severe steroid-dependent chronic urticaria to rituximab
    • Mallipeddi R., Grattan C.E. Lack of response of severe steroid-dependent chronic urticaria to rituximab. Clin Exp Dermatol 2007, 32:333-334.
    • (2007) Clin Exp Dermatol , vol.32 , pp. 333-334
    • Mallipeddi, R.1    Grattan, C.E.2
  • 57
    • 70350461271 scopus 로고    scopus 로고
    • Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra)
    • Bodar E.J., Simon A., de Visser M., van der Meer J.W. Complete remission of severe idiopathic cold urticaria on interleukin-1 receptor antagonist (anakinra). Neth J Med 2009, 67:302-305.
    • (2009) Neth J Med , vol.67 , pp. 302-305
    • Bodar, E.J.1    Simon, A.2    de Visser, M.3    van der Meer, J.W.4
  • 58
    • 84868306171 scopus 로고    scopus 로고
    • Efficiency of interleukin-1 blockade in refractory delayed-pressure urticaria
    • Lenormand C., Lipsker D. Efficiency of interleukin-1 blockade in refractory delayed-pressure urticaria. Ann Intern Med 2012, 157:599-600.
    • (2012) Ann Intern Med , vol.157 , pp. 599-600
    • Lenormand, C.1    Lipsker, D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.